ARIAD Pharma (ARIA) Prices 15.3M Offering at $19.60/Share
Get Alerts ARIA Hot Sheet
Join SI Premium – FREE
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) announced the pricing of an underwritten public offering of 15,307,000 shares of its common stock, at a price to the public of $19.60 per share. The offering is expected to close on or about January 29, 2013, subject to customary closing conditions. In addition, ARIAD has granted the underwriters a 30-day option to purchase up to 2,296,050 additional shares of common stock to cover over-allotments, if any.
J.P. Morgan Securities LLC, Cowen and Company, LLC and Jefferies & Company, Inc. are acting as joint book-running managers and underwriters for the offering. BMO Capital Markets, Leerink Swann LLC, RBC Capital Markets, LLC and UBS Investment Bank are acting as co-managers for the offering.
J.P. Morgan Securities LLC, Cowen and Company, LLC and Jefferies & Company, Inc. are acting as joint book-running managers and underwriters for the offering. BMO Capital Markets, Leerink Swann LLC, RBC Capital Markets, LLC and UBS Investment Bank are acting as co-managers for the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stoke Therapeutics Inc. (STOK) Prices Upsized $125M Share and Warrant Offering at $13.50/sh
- Pyxis Oncology (PYXS) Announces 10.46M Share Offering by Selling Stockholders
- iClick Interactive Asia Group Limited (ICLK) Appoints Josephine Ngai as CFO
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
UBS, JPMorgan, Jefferies & Co, BMO Capital, RBC Capital, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!